期刊文献+

培美曲塞单药或联合奈达铂治疗晚期恶性肿瘤的护理 被引量:4

下载PDF
导出
摘要 目的探讨培美曲塞单药或联合奈达铂治疗晚期恶性肿瘤的护理。方法对4例患者应用培美曲塞单药、6例患者应用培美曲塞联合奈达铂化疗,观察用药过程中的不良反应,采取相应护理措施。结果用药的同时,通过心理护理及观察皮肤毒性反应、胃肠道反应、血液学毒性、肾脏毒性反应及监测肝功能监测,并对症处理,10例患者均安全完成4个周期的治疗。结论培美曲塞单药或联合奈达铂治疗晚期恶性肿瘤患者,效果好且不良反应小,用药时掌握正确的给药方法,制定合理、有效的护理措施,可使患者顺利完成治疗,延长生存时间、提高生活质量。
出处 《现代中西医结合杂志》 CAS 2013年第1期92-93,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献5

二级参考文献55

  • 1[1]HANAUSKE AR,CHEN V,PAOLETTI P,et al.Pemetrexed disodium:a novel antifolate clinically active against multiple solid tumors [J].Oncologist,2001,6(4):363-373.
  • 2[2]ADJEI AA.Pemetrexed:a multitargeted antifolate agent with promising activity in solid tumors [J].Ann Oncol,2000,11(10):1335-1341.
  • 3[3]SCHULTZ RM,PATEL VF,WORZALLA JF,et al.Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate,LY231514 [J].Anticancer Res,1999,19(1A):437-443.
  • 4[4]TEICHER BA,CHEN V,SHIH C,et al.Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.[J].Clin Cancer Res,2000,6(3):1016-1023.
  • 5[5]FOSSELLA FV,GATZEMEIER U.Phase I trials of pemetrexed [J].Semin Oncol,2002,29(2 Suppl 5):8-16.
  • 6[6]RINALDI DA,KUHN JG,BURRIS HA,et al.A phase I evaluation of multitargeted antifolate (MTA,LY231514),administered every 21 days,utilizing the modified continual reassessment method for dose escalation [J].Cancer Chemother Pharmacol,1999,44(5):372-380.
  • 7[7]THODTMANN R,DEPENBROCK H,DUMEZ,et al.Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin [J].J Clin Oncol,1999,17(10):3009-3016.
  • 8[8]HUGHES A,CALVERT P,AZZABI A,et al.Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma [J].J Clin Oncol,2002,20(16):3533-3544.
  • 9[9]RUSTHOVEN JJ,EISENHAUER E,BUTTS C,et al.Targeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer:a phase II study.National Cancer Institute of Canada Clinical Trials Group [J].J Clin Oncol,1999 ,17(4):1194.
  • 10[10]CLARKE SJ,ABRATT R,GOEDHALS L,et al.Phase II trial of pemetrexed disodium (ALIMTA,LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer [J].Ann Oncol,2002,13(5):737-741.

共引文献81

同被引文献31

  • 1Torpy J M,Burke A E,Golub R M. JAMA patient page. Ovari- an cancer[J]. JAMA,2011,305(23) :2484.
  • 2Therasse P,Eisenhauer E A,Verweij J. RECIST revisited:a review of validation studies on tumour assessment[J]. Eur J Cancer, 2006, 42(8):1031-1039.
  • 3A1 Rawahi T,'Lopes A D, Bristow R E, et al. Surgical cytore- duction for recurrent epithelial ovarian cancer[-J']. Cochrane Database Syst Rev, 2013,2 : CD008765.
  • 4Bookman M A. First-line chemotherapy in epithelial ovarian cancer[J]. Clin Obstet Gynecol,2012,55(1) :96-113.
  • 5Tomao F, Panici P B, Frati L, et al. Emerging role of peme- trexed in ovarian cancer[J]. Expert Rev Anticancer Ther, 2009,9(12) : 1727-1735.
  • 6Matulonis U A, Horowitz N S, Campos S M, et al. Phase II study of carhoplatin and pemetrexed for the treatment of plat- inum-sensitive recurrent ovarian cancer [J]. J Clin Oncol, 2008,26(35) :5761-5766.
  • 7Socinski M A,Weissman C, Hart L L, et al. Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer[J]: J Clin Oncol, 2006,24(30) : 4840-4847.
  • 8余春华,李俊英,符琰.培美曲塞治疗晚期非小细胞肺癌过程中毒副反应的观察与护理[J].华西医学,2009,24(4):1009-1012. 被引量:5
  • 9江可云,谢丽芳.恶性肿瘤化疗引起胃肠道反应的预防和护理要点[J].国际医药卫生导报,2010,16(5):599-601. 被引量:13
  • 10李树霞,刘井利,史丽民,陈凤萍,刘建平,李秀芬.营养支持治疗胃肠道恶性肿瘤营养不良患者230例疗效观察[J].山东医药,2011,51(16):93-95. 被引量:17

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部